One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1016/s1556-0864(23)00335-0
Copy DOI
Export
Save
Share
Cite Journal: Journal of Thoracic Oncology |  Publication Date: Apr 1, 2023 |
 Citations: 3 |
Affiliation: Sarah Cannon, University of California, Irvine Medical Center, Vall d'Hebron Institute of Oncology, Fred Hutch Cancer Center, Institut Gustave Roussy, University Cancer Institute Toulouse Oncopole, University of Colorado Cancer Center, Henry Ford Hospital, Memorial Sloan Kettering Cancer Center, Cornell University, The University of Texas MD Anderson Cancer Center, Princess Margaret Cancer Centre, Georgetown University, Covalent Associates (United States), Massachusetts General Hospital
81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK) inhibitor, in patients with advanced ALK-positive solid tumors: The phase I/II ALKOVE-1 study
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
